-
-
Biomarkers for cancer therapy
-
Patent number 12,163,193
-
Issue date Dec 10, 2024
-
Beijing Percans Oncology Co., Ltd.
-
Xiang Li
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
-
Bioactive renal cells
-
Patent number 12,157,887
-
Issue date Dec 3, 2024
-
ProKidney
-
Timothy A. Bertram
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
-
Gene therapy vector contamination assay
-
Patent number 12,152,281
-
Issue date Nov 26, 2024
-
Trizell Ltd.
-
Hanna Peltonen
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
-
-
BCR-ABL variants
-
Patent number 12,153,049
-
Issue date Nov 26, 2024
-
Quest Diagnostics Investments LLC
-
Maher Albitar
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
Targeting human satellite II (HSATII)
-
Patent number 12,152,241
-
Issue date Nov 26, 2024
-
The General Hospital Corporation
-
David T. Ting
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
-
-
-
-
-
-
-
Biomarkers for diabetes therapy
-
Patent number 12,139,761
-
Issue date Nov 12, 2024
-
Katholieke Universiteit Leuven
-
Constantia Gysemans
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
-
-
-
-
Methods for subtyping of lung adenocarcinoma
-
Patent number 12,139,763
-
Issue date Nov 12, 2024
-
GeneCentric Therapeutics, Inc.
-
Hawazin Faruki
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
Treatment of cholangiocarcinoma
-
Patent number 12,133,851
-
Issue date Nov 5, 2024
-
JANSSEN PHARMACEUTICA NV
-
Jacqueline Cirillo Bussolari
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
-
-
-
-
-
-
CDC7 kinase inhibitors and uses thereof
-
Patent number 12,109,189
-
Issue date Oct 8, 2024
-
Sloan-Kettering Institute for Cancer Research
-
Mark G. Frattini
-
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...